Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.35 USD | -2.62% | -5.10% | -37.38% |
May. 07 | Transcript : Harvard Bioscience, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 Revenue $24.5M | MT |
Financials (USD)
Sales 2024 * | 112M | Sales 2025 * | 124M | Capitalization | 146M |
---|---|---|---|---|---|
Net income 2024 * | -3M | Net income 2025 * | 3M | EV / Sales 2024 * | 1.31 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.18 x |
P/E ratio 2024 * |
-42.1
x | P/E ratio 2025 * |
44.9
x | Employees | 404 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.72% |
Latest transcript on Harvard Bioscience, Inc.
1 day | -2.62% | ||
1 week | -5.10% | ||
Current month | -12.30% | ||
1 month | -15.62% | ||
3 months | -25.88% | ||
6 months | -21.73% | ||
Current year | -37.38% |
Managers | Title | Age | Since |
---|---|---|---|
James Green
CEO | Chief Executive Officer | 65 | 15-04-27 |
Jennifer Cote
DFI | Director of Finance/CFO | 52 | 22-04-30 |
David Balcom
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
James Green
CEO | Chief Executive Officer | 65 | 15-04-27 |
Alan Edrick
BRD | Director/Board Member | 56 | 19-09-02 |
Bertrand Loy
BRD | Director/Board Member | 58 | 14-11-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.37% | 4 M€ | -5.15% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +3.87% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 3.37 | -2.03% | 57,415 |
24-05-16 | 3.44 | -0.29% | 60,976 |
24-05-15 | 3.45 | +0.58% | 71,084 |
24-05-14 | 3.43 | +1.18% | 97,727 |
24-05-13 | 3.39 | -3.97% | 80,885 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.38% | 146M | |
+12.15% | 227B | |
+14.90% | 197B | |
+18.22% | 141B | |
+29.15% | 110B | |
+0.53% | 64.15B | |
+16.92% | 53.72B | |
+6.33% | 51.75B | |
+10.93% | 45.2B | |
+5.87% | 37.37B |
- Stock Market
- Equities
- HBIO Stock